Clover health investments, corp. CLOV.US AI Analysis
BetaUS StockHealthcare
(No presentation for CLOV)
CLOV Value Score
3
24
15
Average Growth
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
CLOV Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of CLOV from 2020-06-12 till Now
- 132.73%
- Cumulative Return
- 18.26%
- Annual Return
- 35.91%
- Volatility
- 0.51
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from June, 2020 to July, 2025. (Total Trades: 1)
| CLOV | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | 100% | 48% | 58% |
| Avg Return | 118.8% | 46.7% | 61.1% |
| Avg Profit | 118.8% | 141.7% | 128% |
| Avg Loss | - | -40.2% | -32.2% |
| Avg Risk-Reward Ratio | - | 352.4% | 398% |